Safety profile
Cerebrolysin side effects
Documented adverse effects of Cerebrolysin, organised by frequency and severity. Most side effects of well-characterised nootropics are mild, dose-related, and resolve on stopping; serious reactions are rare but worth knowing.
Safety score
3 / 5
Moderate: meaningful risks at high dose or in vulnerable users
Total documented
2
distinct adverse effects in our dataset
Severe reactions
0
reported severe reactions on file
Common side effects
- Injection-site reactionsmild
Uncommon side effects
- Vertigomild
Rare side effects
No rare side effects on file. This does not mean none exist — rare reactions are by definition under-reported.
When to reduce dose
- Any of the common side effects appear and do not resolve over 3–5 days.
- You have escalated dose recently — drop back to the previous tolerated step rather than pushing through.
- You have added a new stack member that mechanistically overlaps with Cerebrolysin — the combined effect at the same individual dose can exceed the sum.
When to stop
- Cardiovascular symptoms — chest pain, palpitations, sustained blood pressure changes — stop immediately and seek medical attention.
- Mood changes that meaningfully affect daily function (sustained anxiety, depression, agitation, ideation of self-harm).
- Allergic or hypersensitivity signs — rash, swelling, breathing difficulty.
- Any severe reaction documented above.
Side effects that usually resolve
- Mild GI upset in the first 1–2 weeks of a new compound usually resolves with continued use or by taking with food.
- Headache on a new cholinergic (Alpha-GPC, CDP-choline) typically reflects too little choline relative to the racetam dose — increase choline or decrease racetam. Headache on a new racetam alone often resolves by adding a choline source.
- Sleep disruption from a daytime stimulant resolves with earlier dosing — most users tolerate caffeine fine before 11 AM and modafinil fine before 10 AM.
- Mild paresthesia (tingling) from beta-alanine is a benign histamine-like sensation and resolves by splitting the dose across the day.
Dosing, mechanism, and stack interactions for Cerebrolysin are on the main reference page — see Cerebrolysin. For dose-specific guidance see Cerebrolysin dosage. To check stack interactions, use the interaction checker.
Side-effect frequency and severity classifications on this page reflect published clinical and observational literature for healthy adults at standard supplement doses. They are not medical advice and do not substitute for consultation with a qualified clinician. Rare and idiosyncratic reactions can occur even with substances classified as well-tolerated. See our full disclaimer.